Administration, MetronomicCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsAngiogenesis InhibitorsAntineoplastic Agents, AlkylatingNeovascularization, PathologicDrug Administration ScheduleXenograft Model Antitumor AssaysAntineoplastic AgentsMice, SCIDChemotherapy, AdjuvantAdministration, OralEndothelial CellsDose-Response Relationship, DrugCombined Modality TherapyCisplatinTreatment OutcomeDoxorubicinNeoadjuvant TherapyDisease-Free SurvivalBreast NeoplasmsEtoposideSurvival AnalysisNeoplasm StagingLung NeoplasmsSurvival RatePrognosisMethotrexateCarboplatinPaclitaxelVinblastineInduction ChemotherapyTaxoidsNeoplasm Recurrence, LocalNeoplasmsIfosfamideDrug Resistance, NeoplasmDeoxycytidineAntimetabolites, AntineoplasticTime FactorsBleomycinOrganoplatinum CompoundsFollow-Up StudiesCytarabineAnthracyclinesSalvage TherapyCarcinoma, Non-Small-Cell LungChemotherapy, Cancer, Regional PerfusionNeutropeniaVomitingNeoplasm MetastasisOvarian NeoplasmsNauseaRadiotherapy DosageAntineoplastic Agents, PhytogenicAdenocarcinomaInfusions, IntravenousTransplantation, AutologousLymphoma, Non-HodgkinRadiotherapyTesticular NeoplasmsProspective StudiesRadiotherapy, AdjuvantHodgkin DiseaseClinical Trials as TopicAntibiotics, Antineoplastic